AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 209 filers reported holding AMICUS THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $7,952,000 | -17.2% | 816,500 | -31.8% | 0.93% | -24.2% |
| Q3 2019 | $9,607,000 | -50.1% | 1,197,900 | -22.3% | 1.23% | -7.8% |
| Q2 2019 | $19,236,000 | -12.0% | 1,541,400 | -4.0% | 1.33% | +31.8% |
| Q1 2019 | $21,847,000 | +191.0% | 1,606,400 | +105.0% | 1.01% | +95.2% |
| Q4 2018 | $7,507,000 | +399.5% | 783,700 | +530.0% | 0.52% | +502.3% |
| Q3 2018 | $1,503,000 | -64.5% | 124,400 | -55.8% | 0.09% | -68.3% |
| Q1 2018 | $4,236,000 | +8.7% | 281,700 | +4.0% | 0.27% | +29.7% |
| Q4 2017 | $3,898,000 | +183.1% | 270,900 | +7.4% | 0.21% | +62.0% |
| Q2 2016 | $1,377,000 | +39.4% | 252,300 | +51.6% | 0.13% | -12.8% |
| Q3 2014 | $988,000 | – | 166,400 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |